FORTEO Market Exclusivity Period (MEP). When will the patents on FORTEO expire, and when will generic FORTEO be available?
When do Forteo patents expire, and what generic alternatives are available?
Forteo is a drug marketed by Lilly and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.
This drug has ninety-four patent family members in thirty-five countries.
The generic ingredient in FORTEO is teriparatide recombinant human. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the teriparatide recombinant human profile page.